RE: Crazily undervalued at £10m!30 Jan 2020 14:03
Please don't jinx things :p
Nothing is certain.
However I think this has a great shot at being a huge winner (hence I've been invested for a long time :p).
We're now at crunch time.
Signs the Woodford situation is being resolved, judging by the trading, or it never actually was a problem, and was simply a fear of it being a problem that led to the deterioration of the share price. Either way, it appears that people are no longer judging it as a problem, and the buying has been steadily increasing.
A deal for LOXL2 from PXS could literally come at any moment and leave the majority of the MCAP underpinned with cash and many many multiples of the MCAP in milestones on top.
Similarly, the SNG001 trial, which was scheduled to finish in April, presumably assuming a normal flu season, must be close to completion, as the flu spike was about 2 months early this year. There would be nothing to stop SNG's management to have been lining up deals contingent on successful data from the trial. So, frankly, from now onwards, there's the potential for a blockbuster RNS.
You pays your money you takes your chances as they say......I'm in for the ride and hopefully it's finally time to for this stock to shine.